News
01-13-2011, 12:10 AM
The Multiple Myeloma Research Foundation (MMRF) today announced that it has entered into a joint collaboration with Synta Pharmaceuticals for the clinical development of ganetespib (formerly STA-9090) in patients with multiple myeloma.
More... (http://www.news-medical.net/news/20110113/MMRF-Synta-collaborate-for-clinical-development-of-ganetespib-in-multiple-myeloma.aspx)
More... (http://www.news-medical.net/news/20110113/MMRF-Synta-collaborate-for-clinical-development-of-ganetespib-in-multiple-myeloma.aspx)